Tag: Altimmune Inc

Insiders Updates

Altimmune Inc’s recently made public that its Director Drutz David acquired Company’s shares for reported $862.0 on Aug 15 ’23.

Analysts Viewpoint

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Analysts Viewpoint

Altimmune Inc’s filing revealed that its Director Drutz David acquired Company’s shares for reported $862.0 on Aug 15 ’23. In

Stock Earnings

In a filing, Altimmune Inc revealed its Director Drutz David acquired Company’s shares for reported $862.0 on Aug 15 ’23.

Featured

Pfizer Inc (PFE) was down -0.45 percent to $37.27 whereas it’s German partner BioNTech SE (BNTX) fell by 3.10 percent